Atherosclerosis - Pipeline Review, H2 2018

Publisher Name :
Date: 11-Sep-2018
No. of pages: 244
Inquire Before Buying

Atherosclerosis - Pipeline Review, H2 2018

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Atherosclerosis - Pipeline Review, H2 2018, provides an overview of the Atherosclerosis (Cardiovascular) pipeline landscape.

Atherosclerosis (or arteriosclerotic vascular disease) is a condition where the arteries become narrowed and hardened due to an excessive build up of plaque around the artery wall. The disease disrupts the flow of blood around the body, posing serious cardiovascular complications. Symptoms of atherosclerosis are chest pain (angina), pain in the leg, arm, and anywhere else that an artery is blocked, shortness of breath, fatigue, confusion (if the blockage affects circulation to the brain) and muscle weakness in the legs from lack of circulation.

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Atherosclerosis - Pipeline Review, H2 2018, provides comprehensive information on the therapeutics under development for Atherosclerosis (Cardiovascular), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Atherosclerosis (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Atherosclerosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I, Preclinical, Discovery and Unknown stages are 4, 3, 4, 46, 10 and 1 respectively. Similarly, the Universities portfolio in Phase I, Preclinical and Discovery stages comprises 1, 20 and 2 molecules, respectively.

Atherosclerosis (Cardiovascular) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope

- The pipeline guide provides a snapshot of the global therapeutic landscape of Atherosclerosis (Cardiovascular).

- The pipeline guide reviews pipeline therapeutics for Atherosclerosis (Cardiovascular) by companies and universities/research institutes based on information derived from company and industry-specific sources.

- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.

- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.

- The pipeline guide reviews key companies involved in Atherosclerosis (Cardiovascular) therapeutics and enlists all their major and minor projects.

- The pipeline guide evaluates Atherosclerosis (Cardiovascular) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.

- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.

- The pipeline guide reviews latest news related to pipeline therapeutics for Atherosclerosis (Cardiovascular)

Reasons to buy

- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.

- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.

- Find and recognize significant and varied types of therapeutics under development for Atherosclerosis (Cardiovascular).

- Classify potential new clients or partners in the target demographic.

- Develop tactical initiatives by understanding the focus areas of leading companies.

- Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.

- Formulate corrective measures for pipeline projects by understanding Atherosclerosis (Cardiovascular) pipeline depth and focus of Indication therapeutics.

- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.

- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Atherosclerosis - Pipeline Review, H2 2018

Table of Contents
Table of Contents 2
Introduction 5
Atherosclerosis - Overview 6
Atherosclerosis - Therapeutics Development 7
Atherosclerosis - Therapeutics Assessment 21
Atherosclerosis - Companies Involved in Therapeutics Development 33
Atherosclerosis - Drug Profiles 50
Atherosclerosis - Dormant Projects 203
Atherosclerosis - Discontinued Products 212
Atherosclerosis - Product Development Milestones 215
Appendix 234

List of Tables
Number of Products under Development for Atherosclerosis, H2 2018
Number of Products under Development by Companies, H2 2018
Number of Products under Development by Universities/Institutes, H2 2018
Products under Development by Companies, H2 2018
Products under Development by Universities/Institutes, H2 2018
Products under Development by Universities/Institutes, H2 2018 (Contd..1), H2 2018
Number of Products by Stage and Target, H2 2018
Number of Products by Stage and Target, H2 2018 (Contd..1), H2 2018
Number of Products by Stage and Target, H2 2018 (Contd..2), H2 2018
Number of Products by Stage and Mechanism of Action, H2 2018
Number of Products by Stage and Mechanism of Action, H2 2018 (Contd..1), H2 2018
Number of Products by Stage and Mechanism of Action, H2 2018 (Contd..2), H2 2018
Number of Products by Stage and Route of Administration, H2 2018
Number of Products by Stage and Molecule Type, H2 2018
Atherosclerosis - Pipeline by Ache Laboratorios Farmaceuticos SA, H2 2018
Atherosclerosis - Pipeline by AFFiRiS AG, H2 2018
Atherosclerosis - Pipeline by Amgen Inc, H2 2018
Atherosclerosis - Pipeline by Annexin Pharmaceuticals AB, H2 2018
Atherosclerosis - Pipeline by AstraZeneca Plc, H2 2018
Atherosclerosis - Pipeline by Athera Biotechnologies AB, H2 2018
Atherosclerosis - Pipeline by Boehringer Ingelheim GmbH, H2 2018
Atherosclerosis - Pipeline by Cardax Inc, H2 2018
Atherosclerosis - Pipeline by Cerenis Therapeutics Holding SA, H2 2018
Atherosclerosis - Pipeline by ChemoCentryx Inc, H2 2018
Atherosclerosis - Pipeline by CohBar Inc, H2 2018
Atherosclerosis - Pipeline by Daiichi Sankyo Co Ltd, H2 2018
Atherosclerosis - Pipeline by DoNatur GmbH, H2 2018
Atherosclerosis - Pipeline by Dybly AG, H2 2018
Atherosclerosis - Pipeline by Esperion Therapeutics Inc, H2 2018
Atherosclerosis - Pipeline by GenKyoTex SA, H2 2018
Atherosclerosis - Pipeline by GlaxoSmithKline Plc, H2 2018
Atherosclerosis - Pipeline by Immusoft Corp, H2 2018
Atherosclerosis - Pipeline by Inotrem SA, H2 2018
Atherosclerosis - Pipeline by Inspyr Therapeutics Inc, H2 2018
Atherosclerosis - Pipeline by Iproteos SL, H2 2018
Atherosclerosis - Pipeline by KineMed Inc, H2 2018
Atherosclerosis - Pipeline by Kowa Co Ltd, H2 2018
Atherosclerosis - Pipeline by LG Chem Ltd, H2 2018
Atherosclerosis - Pipeline by LipimetiX Development Inc, H2 2018
Atherosclerosis - Pipeline by MedImmune LLC, H2 2018
Atherosclerosis - Pipeline by NuSirt Biopharma Inc, H2 2018
Atherosclerosis - Pipeline by Omeros Corp, H2 2018
Atherosclerosis - Pipeline by Regeneron Pharmaceuticals Inc, H2 2018
Atherosclerosis - Pipeline by Shin Poong PharmCo Ltd, H2 2018
Atherosclerosis - Pipeline by The Medicines Company, H2 2018
Atherosclerosis - Pipeline by Tolerys SA, H2 2018
Atherosclerosis - Pipeline by Vascular Biogenics Ltd, H2 2018
Atherosclerosis - Pipeline by Vicore Pharma AB, H2 2018
Atherosclerosis - Pipeline by XBiotech Inc, H2 2018
Atherosclerosis - Dormant Projects, H2 2018

List of Figures
Number of Products under Development for Atherosclerosis, H2 2018
Number of Products under Development by Companies, H2 2018
Number of Products under Development by Universities/Institutes, H2 2018
Number of Products by Top 10 Targets, H2 2018
Number of Products by Stage and Top 10 Targets, H2 2018
Number of Products by Top 10 Mechanism of Actions, H2 2018
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2018
Number of Products by Routes of Administration, H2 2018
Number of Products by Stage and Routes of Administration, H2 2018
Number of Products by Top 10 Molecule Types, H2 2018
Number of Products by Stage and Top 10 Molecule Types, H2 2018
  • Global Pitavastatin Market Data Survey Report 2025
    Published: 14-Nov-2018        Price: US 1500 Onwards        Pages: 74
    Summary The global Pitavastatin market will reach Volume Million USD in 2018 with CAGR xx% 2018-2025. The main contents of the report including: Global market size and forecast Regional market size, production data and export & import Key manufacturers (manufacturing sites, capacity and production, product specifications etc.) Major Application Major Type Key manufacturers are included based on manufacturing sites, capacity and production, product......
  • Global Digoxin Market Insights, Forecast to 2025
    Published: 06-Nov-2018        Price: US 3900 Onwards        Pages: 114
    This report researches the worldwide Digoxin market size (value, capacity, production and consumption) in key regions like United States, Europe, China, Japan and other regions. This study categorizes the global Digoxin breakdown data by manufacturers, region, type and application, also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.......
  • Global Cilostazol Market Insights, Forecast to 2025
    Published: 01-Nov-2018        Price: US 3900 Onwards        Pages: 123
    This report studies the global market size of Cilostazol in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Cilostazol in these regions. This research report categorizes the global Cilostazol market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenge......
  • Global Rosuvastatin Market Insights, Forecast to 2025
    Published: 30-Oct-2018        Price: US 3900 Onwards        Pages: 126
    This report studies the global market size of Rosuvastatin in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Rosuvastatin in these regions. This research report categorizes the global Rosuvastatin market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and cha......
  • Global Heart Failure Drugs Market Research Report 2018
    Published: 25-Oct-2018        Price: US 2900 Onwards        Pages: 115
    This report studies the global Heart Failure Drugs market status and forecast, categorizes the global Heart Failure Drugs market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report - Amgen - AstraZeneca - Bayer - Novartis - Gilead - GlaxoSmithKline......
  • Global Congestive Heart Failure Drugs Market Insights, Forecast to 2025
    Published: 16-Oct-2018        Price: US 3900 Onwards        Pages: 123
    In 2017, the global Congestive Heart Failure Drugs market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. The objectives of this study are to define, segment, and project the size of the Congestive Heart Failure Drugs market based on company, product type, application and key regions. This report studies the global market size of Congestive Heart Failure Drugs in key regions like North America, Europe, Asia Pacific, Central & South Ameri......
  • Global Simvastatin Market Insights, Forecast to 2025
    Published: 10-Oct-2018        Price: US 3900 Onwards        Pages: 122
    In 2017, the global Simvastatin market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. The objectives of this study are to define, segment, and project the size of the Simvastatin market based on company, product type, application and key regions. This report studies the global market size of Simvastatin in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumptio......
  • Behcet Disease - Pipeline Review, H2 2018
    Published: 09-Oct-2018        Price: US 2000 Onwards        Pages: 66
    Behcet Disease - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Behcet Disease - Pipeline Review, H2 2018, provides an overview of the Behcet Disease (Cardiovascular) pipeline landscape. "Behcet disease (BEH-chets), sometimes called Behcet syndrome, Morbus Behçet, or Silk Road disease, is a rare immune-mediated systemic vasculitis. The more common symptoms include sores in the mouth and o......
  • Hypertrophic Cardiomyopathy - Pipeline Review, H2 2018
    Published: 09-Oct-2018        Price: US 2000 Onwards        Pages: 54
    Hypertrophic Cardiomyopathy - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hypertrophic Cardiomyopathy - Pipeline Review, H2 2018, provides an overview of the Hypertrophic Cardiomyopathy (Cardiovascular) pipeline landscape. Hypertrophic cardiomyopathy (HCM) is a disease in which the heart muscle (myocardium) becomes abnormally thick (hypertrophied). The thickened heart muscles make it h......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs